The Lancet Oncology

SJR Rank #97H-index: 455SJR: 9.432Best quartile: Q1APC: US$7,280
Journal website: aims, scope and author guidelines
Publisher

Elsevier Ltd

Country

United Kingdom

Type

journal

SJR by Edition

202220250481216

Subject Categories

  • OncologyQ1

Areas: Medicine

Most published research topics

Lung Cancer Treatments and MutationsGlobal Cancer Incidence and ScreeningEconomic and Financial Impacts of CancerAdvances in Oncology and RadiotherapyCancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesProstate Cancer Treatment and ResearchCancer Genomics and DiagnosticsHealth Systems, Economic Evaluations, Quality of LifeColorectal Cancer Treatments and Studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs035070010501400

Documents per Year

202220250150300450600

Detailed Information

ISSN

1470-2045, 1474-5488

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

9.41

References per Document

19.32

Coverage

2000-2026

Scope

The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice. Topics include, but are not limited to: Breast cancer; Endocrine system cancer; Gastrointestinal cancer; Genitourinary cancer; Gynaecological cancer; Haematological cancer; Head and neck cancer; Neurooncology; Paediatric oncology; Thoracic oncology; Sarcoma; Skin cancer; Epidemiology, cancer prevention, and cancer control; Supportive care; Imaging; Health-care systems.

Metrics from SCImago Journal Rank 2025. View on SCImago